Basic Information
Basic information for MIR4300HG-213-16aa-1
Peptide Name MIR4300HG-213-16aa-1
Genome Position chr11:82356553-82356600[-]
Species Human
Peptide Sequence MESLLWQKTDVSSQQH
Peptide Length 16
Unique No (MIR4300HG-201-16aa-1,MIR4300HG-203-16aa,MIR4300HG-204-16aa,MIR4300HG-205-16aa-1,MIR4300HG-206-16aa,MIR4300HG-207-16aa,MIR4300HG-208-16aa,MIR4300HG-209-16aa-1,MIR4300HG-210-16aa-1,MIR4300HG-211-16aa,MIR4300HG-212-16aa)
Grand Average of Hydropathicity -0.9312
Relative Molecular Mass 2187.38
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000245832;MIR4300HG
Transcript ID/Name ENST00000671244;MIR4300HG-213
Transcript Length 1047
Coding Ability 0.3973
DNA Sequence Corresponding to Peptide ATGGAAAGTCTGTTGTGGCAGAAAACTGATGTCTCCAGCCAACAGCAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :